Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation Maura R.V. Ikoma-Colturato, Miriam P. Beltrame, Felipe M. Furtado, Glicinia Pimenta, Elaine Sobral da Costa, Ana Paula Azambuja, Mariester Malvezzi, Mihoko Yamamoto

Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia Carina Maria Pinto, Camila Marques Bertolucci, Alef Rafael Severino, Juliana Fernanda dos Santos Tosi, Maura R V Ikoma-Colturato

ASSESSMENT OF MINIMAL RESIDUAL DISEASE BY NEXT-GENERATION FLOW CYTOMETRY AFTER INITIAL INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA IN A PUBLIC PEDIATRIC HOSPITAL MCC Magalhães, RM Pontes, FM Furtado, BC Guido, ACMD Santos-Junior, RA Toscano, IMQ Magalhães, R Camargo, JCM Códoba